Analyst picks & changes

Oncogene Science Inc.

(ONCS)

Michael Ehrenreich of Ehrenreich & Co. initiated coverage with an "overweight" rating. His recommendation was based

Read the full 202 word article

How to gain access

Continue reading with a
two-week free trial.